Triglyceride-glucose index and heart failure: a systematic review and meta-analysis.

Authors:
Khalaji A; Behnoush AH; Khanmohammadi S; Ghanbari Mardasi K; Sharifkashani S and 3 more

Journal:
Cardiovasc Diabetol

Publication Year: 2023

DOI:
10.1186/s12933-023-01973-7

PMCID:
PMC10486123

PMID:
37679763

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cardiovasc Diabetol

Abbreviation: Cardiovasc Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronar…
Kim J; Kim D; Bae HJ and 9 more (2024) - Transparency Score: 3/6
Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of…
Wu X; Qiu W; Yang H and 3 more (2024) - Transparency Score: 3/6
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Januzzi JL; Del Prato S; Rosenstock J and 11 more (2024) - Transparency Score: 4/6
Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD pati…
Liu Y; Liu JE; He H and 7 more (2024) - Transparency Score: 3/6
Circulating exosomal mir-16-2-3p is associated with coronary microvascular dysfunction in diabetes …
Liu Y; Zhong C; Chen S and 4 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding None."

Evidence found in paper:

"This systematic review and meta-analysis was registered in PROSPERO (Registration Number: CRD42023437470) and was conducted in accordance with the Preferred Reporting Item for Systematic Reviews and Meta-Analysis (PRISMA) 2020 recommendations []."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025